For example, the drug combination, but not single treatments, downregulated expression of RPS6KA2, LY6E, NUSAP1, NUAK2 and PAICS, five genes reported to promote PCa development and progression [25–31]. This evidence concerns the gene RPS6KA2 and posterior cortical atrophy.